EUVIMEDEUVIMED entdecken
Crossref

Biomarker‐agnostic antibody‐drug conjugates in chemotherapy‐refractory metastatic colorectal cancer: a single‐centre retrospective pooled analysis of early‐phase clinical trials

Asia-Pacific Journal of Clinical Oncology · 2026-11 · 22 (S6) · 14-14

DOI: 10.1111/ajco.70229 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Asia-Pacific Journal of Clinical Oncology, online erschienen am 19.11.2026.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

(2026). Biomarker‐agnostic antibody‐drug conjugates in chemotherapy‐refractory metastatic colorectal cancer: a single‐centre retrospective pooled analysis of early‐phase clinical trials. Asia-Pacific Journal of Clinical Oncology, 22(S6), 14-14. https://doi.org/10.1111/ajco.70229

Vancouver

Biomarker‐agnostic antibody‐drug conjugates in chemotherapy‐refractory metastatic colorectal cancer: a single‐centre retrospective pooled analysis of early‐phase clinical trials. Asia-Pacific Journal of Clinical Oncology. 2026;22(S6):14-14. doi:10.1111/ajco.70229

BibTeX
@article{euvimed2026,
  title = {Biomarker‐agnostic antibody‐drug conjugates in chemotherapy‐refractory metastatic colorectal cancer: a single‐centre retrospective pooled analysis of early‐phase clinical trials},
  journal = {Asia-Pacific Journal of Clinical Oncology},
  year = {2026},
  volume = {22},
  number = {S6},
  pages = {14--14},
  doi = {10.1111/ajco.70229}
}
Kostenlos starten →